Sanofi's first quarter boosted by eczema treatment and vaccines

Sanofi's first quarter boosted by eczema treatment and vaccines

CNBC's Charlotte Reed reports on Sanofi's first-quarter results which came in line with expectations, while the French pharmaceutical still works on its delayed Covid-19 vaccines.